G A Sarosi, J D Parker, I L Doto, F E Tosh. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAgedAmphotericin B/therapeutic useCerebrospinal Fluid/microbiologyCryptococcosis/drug therapyCryptococcus/isolation & purificationDiabetes ComplicationsFemaleFollow-Up StudiesHodgkin Disease/complicationsHumansLeukemia, Lymphoid/complicationsLupus Erythematosus, Systemic/complicationsMaleMeningitis/complicationsMeningitis/drug therapyMiddle AgedSarcoidosis/complicationsSilicosis/complications
Substances: See more » Amphotericin B
Year: 1969 PMID: 5361407 DOI: 10.7326/0003-4819-71-6-1079
Source DB: PubMed Journal: Ann Intern Med ISSN: 0003-4819 Impact factor: 25.391